Showing 1331-1340 of 1968 results for "".
- Allergan Aesthetics Panel: Medical Weight Loss Fuels New Aesthetic Conversationshttps://modernaesthetics.com/news/allergan-aesthetics-panel-medical-weight-loss-fuels-new-aesthetic-conversations/2485952/Experts at Allergan Aesthetics’ “Navigating the New Era of Patient Needs” virtual event highlighted how GLP-1 receptor agonists (GLP-1 RAs) are changing facial aesthetic concerns, patient education, and treatment sequencing. Th
- Adipocytes Emerge as Central Drivers of Skin Aging in New Reviewhttps://modernaesthetics.com/news/adipocytes-emerge-as-central-drivers-of-skin-aging-in-new-review/2485879/A recent review in Biogerontology reframes skin aging by positioning adipocytes—particularly dermal white adipose tissue (dWAT)—as central regulators of age-related cutaneous change. Traditionally, skin aging has been attributed to epidermal and dermal alterations, including keratinocyte
- Photocurable Collagen Filler Aims to Address Weight-Loss–Associated Facial Deflationhttps://modernaesthetics.com/news/photocurable-collagen-filler-aims-to-address-weight-lossassociated-facial-deflation/2485851/CollPlant Biotechnologies announced the strategic positioning of its photocurable dermal filler platform to address facial volume loss associated with rapid weight reduction, including in patients treated with glucagon-like peptide-1 receptor agonists (GLP-1 RA) for metabolic health and weight ma
- The Rise of Biostimulators: Complement, Not Competitor, in Aesthetic Regimenshttps://modernaesthetics.com/news/the-rise-of-biostimulators-complement-not-competitor-in-aesthetic-regimens/2485824/The filler category of medical aesthetics may have faced certain headwinds in 2025, but biostimulatory agents experienced a noticeable uptick. Still, at the 2026 Octane Aesthetics Tech Forum, “Flipping the Filler Script” panelists cautioned against viewing them as a replacement for hyaluronic aci
- Lynch Regenerative Medicine Names General Counsel, CMOhttps://modernaesthetics.com/news/lynch-regenerative-medicine-names-general-counsel-cmo/2485740/Lynch Regenerative Medicine (LRM), a regenerative medicine company focused on platelet-derived growth factor–based therapies, has named Madison Dini as General Counsel and Chad Lindemann as Chief Marketing Officer. According to the company, Dini will lead legal, compliance, and corporate g
- Octane Aesthetics Tech Forum: Strategy Over Syringes Leads 2025 Filler Reboundhttps://modernaesthetics.com/news/octane-aesthetics-tech-forum-strategy-over-syringes-leads-2025-filler-rebound/2485717/“Flipping the Filler Script” was a hot topic at the 2026 Octane Aesthetics Tech Forum held January 8 and 9 in Newport Beach, California. The panel was moderated by Jason D. Bloom, MD, FACS, of Bloom Facial Plastic Surgery in Bryn Mawr, Pennsylvania, and panelists included Shawna Chrisman, NP, Chi
- New JDD Study Explores Aesthetic Motivations of African American Womenhttps://modernaesthetics.com/news/new-jdd-study-explores-aesthetic-motivations-of-african-american-women/2485593/A new survey-based study published in Journal of Drugs in Dermatology examines the cosmetic concerns, motivations, and skincare behaviors that shape the aesthetic journey of African American (AA) women, highlighting hair loss and hyperpigmentation as leading priorities in this population
- Octane Aesthetics Tech Forum: Clinical Strategies for Managing Rapid Weight Loss in Aestheticshttps://modernaesthetics.com/news/octane-aesthetics-tech-forum-clinical-strategies-for-managing-rapid-weight-loss-in-aesthetics/2485537/The widespread use of GLP-1 receptor agonists (GLP-1 RAs) is ushering in a new era of aesthetic medicine that demands a more nuanced approach to skin aging, hormonal health, and treatment planning. That was the consensus from a panel of aesthetic surgeons and regenerative medicine experts
- Octane Aesthetics Tech Forum: 3 Big Trends from GuidePoint Qsight’s 2025 Market Analysishttps://modernaesthetics.com/news/octane-aesthetics-tech-forum-3-big-trends-from-guidepoint-qsights-2025-market-analysis/2485514/At the 2026 Octane Aesthetic Tech Forum, Erik Haines, Managing Director of Guidepoint Qsight, presented a data-rich snapshot of the state of the medical aesthetics industry. Drawing from over $17 billion in transactional data across 45,000 aesthetic practices and millions of patient records, Hain
- Octane Aesthetics Tech Forum: GLP-1 Receptor Agonists Are Reshaping Consumer Behavior and Aesthetic Business Modelshttps://modernaesthetics.com/news/octane-aesthetics-tech-forum-glp-1-receptor-agonists-are-reshaping-consumer-behavior-and-aesthetic-business-models/2485431/The rise of GLP-1 receptor agonist (GLP-1RA) medications is doing more than transforming bodies; it is reshaping the very business of aesthetics. At the 2026 Octane Aesthetics Tech Forum, panelists described how GLP-1RAs are influencing patient behavior, redefining value propositions, and catalyz